Last reviewed · How we verify
NCT07511790: PBMT
Photobiomodulation on Performance in Female Futsal Athletes
NA trial testing Active PBMT in Muscle Performance in 15 participants. Not yet recruiting.
1 June 2026
Quick facts
| Lead sponsor | Universidade Norte do Paraná |
|---|---|
| Phase | NA |
| Status | Not yet recruiting |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | crossover |
| Masking | double |
| Primary purpose | treatment |
| Enrollment | 15 |
| Start date | 15 April 2026 |
| Primary completion | 1 June 2026 |
| Estimated completion | 10 June 2026 |
Drugs / interventions tested
- Active PBMT
- Placebo PBMT
Conditions studied
- Muscle Performance — all drugs for Muscle Performance →
- Exercise — all drugs for Exercise →
- Phototherapy — all drugs for Phototherapy →
- Futsal — all drugs for Futsal →
Sponsor
Universidade Norte do Paraná
Who can join
Adults 18 to 35, female only, with Muscle Performance or Exercise. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The aim of this study is to investigate the effects of photobiomodulation therapy (PBMT) on physical performance in female futsal athletes. It is hypothesized that PBMT is superior to placebo condition in improving the ability to perform repeated sprints and aerobic capacity in high-intensity, intermittent activity (i.e., Bangsbo sprint test and yoyo intermittent recovery level-1, respectively).
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT07511790
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Active PBMT
Trials testing the same drug.
- NCT07511803 — Photobiomodulation on Recovery in Female Futsal Athletes · NA · not yet recruiting
- NCT06549660 — PBMT in Providing Temporary Relief of Low Back Pain of Musculoskeletal Origin · NA · recruiting
- NCT04476095 — Photobiomodulation Therapy (PBMT) in Patients With Low Back Pain (LBP) · NA · unknown
- NCT04322812 — Effects of Photobiomodulation Therapy Combined With Static Magnetic Field in Patients With Fibromyalgia · NA · completed
- NCT03859505 — Photobiomodulation Therapy on Inflammatory Mediators on Low Back Pain · NA · completed
Other recruiting trials for Muscle Performance
Currently open trials in the same condition.
- NCT06600581 — Safety and Efficacy of IMM01-STEM Against Placebo on Muscle Performance in Seniors With Obesity and Muscle Weakness · Phase 2 · active not recruiting
Other Universidade Norte do Paraná trials
Trials by the same sponsor.
- NCT07511803 — Photobiomodulation on Recovery in Female Futsal Athletes · NA · not yet recruiting
- NCT07379385 — Effects of Weekly Set Volume on Muscle Adaptation · NA · enrolling by invitation
- NCT06562322 — Acute Effect of Photobiomodulation Therapy on Muscle Performance in Female Futsal Players · NA · completed
- NCT05241223 — An Online Behavior Change Intervention to Promote Physical Activity in Adults With Asthma · NA · completed
- NCT04887987 — Effects of Different Exercise Programs Plus Photobiomodulation on Non-specific Low-back Pain. · NA · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT07511790 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Universidade Norte do Paraná
- Last refreshed: 6 April 2026
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07511790.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing